Title of Invention

A PROCESS OF PREPARATION OF AN ANTIDIABETES/BLOOD SUGAR REGULATING PRODUCT FROM GLYCINE MAX (SOYBEAN) SEEDS

Abstract

Process of preparation of blood sugar regulating/ anti-diabetes product from soybean seeds comprising the following steps: a. soaking the soybean seeds, b. germination of soybean seeds, c. optionally if required, drying the soaked/germinated soybean seed to reduce the water content of seeds, d. optionally if required, grinding the dried soaked/germinated soybean seeds, e. optionally if required, extracting the active ingredients from said seed by known methods.

Full Text

THIS INVENTION RELATES TO A PROCESS OF PREPARATION OF A BLOOD SUGAR REGULATING PRODUCT FROM SOYABEAN SEEDS PRIOR ART: Diabetes is a disease where the sugar level of the blood increases. This increase in the sugar level of the blood causes many other physiological problems. Some of the physiological problems become fatal while others reduce the life span of the individual by 10 to 15 years and in certain cases by even more than this. The exact reason for diabetes is not yet known. But its apparent cause and its control give us indication for some of the probable factors like increase in stress, change in lifestyle, malnourished diet and increase of fatty acids in the body, which create resistance in Insulin action. Diabetes is broadly classified in two types, type-1 and type-ll. Till today diabetes is mainly controlled by allopathic medicines, which comprises oral drugs and insulin injections. But unfortunately these medicines are not able to control diabetes perfectly rather they increase the severity of the disease and many times the side effects of these drugs are fatal. I have seen many simple diabetes patients just dying because of the adverse side effects of the drugs for controlling diabetes and hypertension. Blood plasma can retain only 2% of sugar. When the sugar concentration rises beyond this 2%, blood becomes thick and it exerts pressure at the wall of the blood vessels. The proteins of the blood come out of the blood to provide space for the extra sugar and thereby PH of the blood falls. This condition many times induces blood pressure. Drawbacks of Prior Art: Treating diabetes patients with allopathic drugs is not a desirable thing always, proven by the scientific world. The side effects of allopathic medicines can be seen widely in diabetes patients. Diabetes patients are left with no option; if they do not control their blood sugar they may die of some or other physiological problems and if they take medicines their blood sugar is temporarily controlled but actually they are becoming severe diabetic from mild. This invention provides a healthy alternative to the diabetes treatment. Insulin resistance is the main cause of the diabetes today. 90% of the diabetes patients are having type-2 diabetes, where insulin resistance is the main cause and 10% are type-1 diabetes, where insulin producing pancreatic B cells go under cell death. Yet no natural therapy is available for overcoming the resistance faced by Insulin. This invention provides a natural therapy for overcoming Insulin resistance. No natural plant product yet is able to control diabetes effectively. This invention provides a simple natural product, which treats diabetes effectively. Object of Invention: Oral drugs and insulin injections are harmful for the body. An early diabetes patient who is controlling his/her blood sugar by various natural plant products is apparently better than a patient who is controlling his or her blood sugar by drugs or insulin injections. This invention is an attempt to achieve the desirable components by applying certain process to natural raw soybean seeds. When a specific process is applied to soybean seeds it turns to an effective antidiabetes product, which is a blood sugar regulator also. It controls both the conditions of hypoglycemia and hyperglycemia. Summary of invention: Novelties and inventive step: Inventive step of the process lies in the soaking and germination of soybean seeds for developing a product for controlling blood sugar.. During embryo development some important ingredients are synthesized or increased in amount which reduce high blood sugar in blood. Inositol compounds are most important among them. I am experimentally investigating whether these ingredients can reduce high blood sugar in isolation without producing any significant harmful effect. I invented that, through soaking and germination (embryo development), soybean seeds can be converted into a highly effective antidiabetes product. Blood sugar regulating activity of soybean seeds is enhanced. By this process certain compounds are generated which activate tyrosine phosphorylation and thereby stimulate insulin receptors. Germination itself is a complex phenomenon. Many ingredients are synthesized/increased, which help in controlling excess sugar in the blood, for example, Many inositols including Phosphatidyl inositol 3 phosphate (PI3P), phosphatidyl inositol 3 kinase (PI3K), phosphatidyl inositol 4 kinase (PI4K), myoinositol dehydrogenase, tyrosine dehydrogenase, leptin, lectins, lecithin, phytic acid, niacin, riboflavin, vitamin C and essential amino acids. Synthesis of certain inositols during embryo development of soybean seed are playing an important role. Detailed Description of the Invention: Here is the process invented by me for obtaining the effective natural product for treating diabetes. I soaked the soybean seeds to achieve the ingredients able to reduce high blood sugar. Certain phosphatidyl inositols including phosphatidyl inositol 3 kinase(PI3K) and PI3P are most important. Besides these two myoinositol dehydrogenase, tyrosine dehydrogenase, leptin,lecithin, phytic acid, niacin, riboflavin, vitamin C and essential amino acids are biologically active compounds obtained by the embryo development of the soybean seeds, which help in reducing blood sugar in synergy or in isolation. Soybean seeds are soaked, germinated. After soaking and germination to get optional product it is further processed. It is dried to get the desired product, such as dry powder. It is worth mentioning here that earlier to this I had conducted trials and found the efficacy of soaked soybean seeds in controlling the blood sugar in diabetes patients by preparing this product in the solution form itself. I had applied for the patent of this invention to the patent office of India through patent application no. 904/DEL/2002. On further investigations I found that the soaked and germinated soybean seeds retain their blood sugar regulating property even if they are dried later. After dryness it can be taken in any form. For its effective acceptance in the body the dried seeds are ground and converted into powder. This product, when taken by diabetes patients, was found to be highly effective blood sugar regulating agent. I observed the efficacy of this product on more than 30 volunteer diabetes patients. This soybean powder is better alternative to other oral hypoglycemic drug as it does not have any harmful effect like them. This natural eatable product, as a medicine, is very cost effective and easily obtainable. I CLAIM: 1. Process of preparation of a blood sugar regulating product, from soybean seeds comprising the following steps: (a) soaking the soybean seeds, (b) germination of soybean seeds, (c) optionally if required, drying the soaked/germinated soybean seeds to reduce the water content of seeds, (d) grinding the dried soaked/germinated soybean seeds, (e) extracting the active ingredients from said seed by known methods. 2. Process of preparation of a blood sugar regulating product from soybean seeds by using step (a) of process claimed in claim! Step (c), step (d) and step (e) are followed directly. 3. A process as claimed in claim 1, wherein extracted compounds are inositols, phosphatidyl inositols, phosphatidyl inositol tri phosphate (PI3P), phosphatidyl inositol 3 kinase (PI3K), phosphatidyl inositol 4 kinase (PI4K), PI4P, myoinositols, myoinositol dehydrogenase, tyrosine dehydrogenase, leptin, lectins, lecithins, phytic acid, vitamins of B group and vitamin C and essential amino acids.

Documents:

663-DEL-2003-Abstract (4-1-2010).pdf

663-del-2003-abstract.pdf

663-DEL-2003-Claims (4-1-2010).pdf

663-del-2003-claims.pdf

663-DEL-2003-Correspondence-Others-(4-1-2010).pdf

663-del-2003-correspondence-others.pdf

663-del-2003-correspondence-po.pdf

663-del-2003-description (complete).pdf

663-del-2003-form-1.pdf

663-del-2003-form-13-(06-03-2009).pdf

663-del-2003-form-13.pdf

663-DEL-2003-Form-15-(24-12-2009).pdf

663-del-2003-form-19.pdf

663-del-2003-form-2.pdf

663-del-2003-form-5.pdf